- Home
- FTS vs DGX Comparison
FTS vs DGX Comparison
Compare FTS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTS
- DGX
- Stock Information
- Founded
- FTS 1885
- DGX 1967
- Country
- FTS Canada
- DGX United States
- Employees
- FTS N/A
- DGX N/A
- Industry
- FTS Electric Utilities: Central
- DGX Medical Specialities
- Sector
- FTS Utilities
- DGX Health Care
- Exchange
- FTS Nasdaq
- DGX Nasdaq
- Market Cap
- FTS 24.6B
- DGX 19.8B
- IPO Year
- FTS N/A
- DGX 1996
- Fundamental
- Price
- FTS $50.77
- DGX $179.81
- Analyst Decision
- FTS Hold
- DGX Buy
- Analyst Count
- FTS 1
- DGX 15
- Target Price
- FTS $72.00
- DGX $185.40
- AVG Volume (30 Days)
- FTS 551.3K
- DGX 1.2M
- Earning Date
- FTS 08-01-2025
- DGX 07-22-2025
- Dividend Yield
- FTS 3.43%
- DGX 1.78%
- EPS Growth
- FTS 6.60
- DGX 12.66
- EPS
- FTS 2.49
- DGX 8.35
- Revenue
- FTS $8,705,438,970.00
- DGX $10,522,000,000.00
- Revenue This Year
- FTS $10.02
- DGX $10.88
- Revenue Next Year
- FTS $3.87
- DGX $3.68
- P/E Ratio
- FTS $20.36
- DGX $21.53
- Revenue Growth
- FTS 4.22
- DGX 12.58
- 52 Week Low
- FTS $40.32
- DGX $146.17
- 52 Week High
- FTS $51.45
- DGX $182.38
- Technical
- Relative Strength Index (RSI)
- FTS 69.79
- DGX 63.71
- Support Level
- FTS $50.36
- DGX $175.56
- Resistance Level
- FTS $51.12
- DGX $179.47
- Average True Range (ATR)
- FTS 0.62
- DGX 2.66
- MACD
- FTS 0.04
- DGX 1.12
- Stochastic Oscillator
- FTS 78.06
- DGX 95.90
About FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving more than 3.4 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.